Development

Fimea developes the pharmaceutical care and sector

In addition to its roles as a licensing and supervisory authority, the Finnish Medicines Agency (Fimea) also has the statutory duties of national coordination and research in the pharmaceutical sector and assessment of pharmacotherapies.

In its research and development activities, Fimea cooperates with other authorities, universities, research institutions, social welfare and health care units and other actors in the sector, both nationally and internationally.

Asset Publisher

A pilot project between Fimea, university hospitals and Sitra is emerging as a model for providing additional evidence on new pharmacotherapies

A pilot project between Fimea, university hospitals and Sitra is emerging as a model for providing additional evidence on new pharmacotherapies 23.4.2024 The three...

FINOSE now includes all Nordic countries

FINOSE now includes all Nordic countries 22.4.2024 | Published in English on 22.4.2024 at 11.24 Iceland’s Landspitali joins the Nordic collaboration FINOSE...

Patient pharmacotherapy checklist supports medication counselling at different stages of treatment

Patient pharmacotherapy checklist supports medication counselling at different stages of treatment 14.3.2024 | Published in English on 14.3.2024 at 10.27 ...

More than a third of people with a long-term illness miss some medicine doses

More than a third of people with a long-term illness miss some medicine doses 14.3.2024 According to the recent population survey Medicines Barometer 2023, people...

Instructions for the safe use of medicines in Northern Sámi

Instructions for the safe use of medicines in Northern Sámi 11.3.2024 | Published in English on 11.3.2024 at 11.46 “Instructions for the safe use of...